Cedar Brook Financial Partners, LLC Merck & Co., Inc. Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $505,970 - $543,407	-4,087 Reduced 69.52%	1,792 $221,000
Q1 2024 Apr 17, 2024	SELL	$113.24 - $131.95 $7,813 - $9,104	-69 Reduced 1.16%	5,879 $775,000
Q4 2023 Jan 12, 2024	SELL	$100.18 - $109.02 $3,105 - $3,379	-31 Reduced 0.52%	5,948 $648,000
Q3 2023 Oct 17, 2023	SELL	$102.95 - $114.33 $65,888 - $73,171	-640 Reduced 9.67%	5,979 $615,000
Q2 2023 Jul 05, 2023	BUY	$108.61 - $118.38 $4,670 - $5,090	43 Added 0.65%	6,619 $763,000
Q1 2023 Apr 04, 2023	SELL	$102.94 - $114.86 $16,470 - $18,377	-160 Reduced 2.38%	6,576 $699,000
Q4 2022 Feb 01, 2023	BUY	$87.44 - $112.11 $43,107 - $55,270	493 Added 7.9%	6,736 $747,000
Q3 2022 Jan 03, 2023	BUY	$84.53 - $94.96 $56,381 - $63,338	667 Added 11.96%	6,243 $537,000
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $2,087 - $2,366	-25 Reduced 0.45%	5,576 $508,000
Q1 2022 Apr 06, 2022	BUY	$73.51 - $82.4 $52,706 - $59,080	717 Added 14.68%	5,601 $460,000
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $722 - $905	10 Added 0.21%	4,884 $374,000
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $14,622 - $16,081	-204 Reduced 4.02%	4,874 $366,000
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $21,655 - $23,953	308 Added 6.46%	5,078 $395,000
Q1 2021 May 11, 2021	SELL	$68.86 - $81.11 $21,690 - $25,549	-315 Reduced 6.19%	4,770 $368,000
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $6,100 - $6,770	85 Added 1.7%	5,085 $416,000
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $19,392 - $21,981	265 Added 5.6%	5,000 $395,000
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $30,069 - $34,215	427 Added 9.91%	4,735 $366,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $31,046 - $43,031	-490 Reduced 10.21%	4,308 $331,000
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $30,023 - $33,877	387 Added 8.77%	4,798 $436,000
Q3 2019 Oct 24, 2019	BUY	$76.08 - $82.93 $20,922 - $22,805	275 Added 6.65%	4,411 $371,000
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $9,218 - $10,769	-132 Reduced 3.09%	4,136 $347,000
Q1 2019 May 08, 2019	BUY	$69.58 - $79.36 $17,047 - $19,443	245 Added 6.09%	4,268 $355,000
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $262,460 - $304,581	4,023 New	4,023 $293,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.6 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.8 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.52 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.87 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account